These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7620180)

  • 1. Role of the cyclin-dependent kinase inhibitors in the development of cancer.
    Hirama T; Koeffler HP
    Blood; 1995 Aug; 86(3):841-54. PubMed ID: 7620180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
    Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2.
    Peters G; Parry D; Hara E; Hall M; Bates S; Palmero I
    Leukemia; 1997 Apr; 11 Suppl 3():352-5. PubMed ID: 9209387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Sherr CJ; Roberts JM
    Genes Dev; 1995 May; 9(10):1149-63. PubMed ID: 7758941
    [No Abstract]   [Full Text] [Related]  

  • 11. p16INK4 mutations and altered expression in human tumors and cell lines.
    Okamoto A; Demetrick DJ; Spillare EA; Hagiwara K; Hussain SP; Bennett WP; Forrester K; Gerwin B; Greenblatt MS; Serrano M
    Cold Spring Harb Symp Quant Biol; 1994; 59():49-57. PubMed ID: 7587103
    [No Abstract]   [Full Text] [Related]  

  • 12. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cell cycle regulators and cancer].
    Figarella-Branger D; Bouvier-Labit C; Civatte M; Pellissier JF
    Ann Pathol; 1998 Jul; 18(3):178-86. PubMed ID: 9706343
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor suppressors and oncogenes in cellular senescence.
    Bringold F; Serrano M
    Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts.
    Wong H; Riabowol K
    Exp Gerontol; 1996; 31(1-2):311-25. PubMed ID: 8706801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.